Skip to main content

Sumitomo Dainippon Pharma Value Stock - Dividend - Research Selection

Sumitomo Dainippon Pharma Co., Ltd.

ISIN: JP3495000006, WKN: 858257

Market price date: 26.01.2022
Market price: 1.314,00 JPY

Sumitomo Dainippon Pharma Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 18-05-2021
Cash flow
Net operating cash flow 135.601.000.000
Capital Expenditures -
Free cash flow 129.552.998.400
Balance sheet
Total Equity 648.178.000.000
Liabilities & Shareholders equity 1.308.130.000.000
Income statement
Net income
Eps (diluted) 141,500
Diluted shares outstanding 397.290.000
Net sales/revenue 515.952.000.000

Fundamental ratios calculated on: 26-01-2022

Key figures 26-01-2022
Cash flow
P/C 3,85
P/FC 4,03
Balance sheet
Income statement
Div. Yield2,13%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization5.033.060.352,00 USD
IndicesNIKKEI 225,MSCI World Index
Raw Data SourceIFRS in Millionen JPY
Stock Split

Description of the company

The Sumitomo Dainippon Pharma Group sets the pharmaceutical business as its core activity but also deploys other operations covering food ingredients, food additives and chemical product materials, animal health products, diagnostics and research materials.


In order to deliver innovative and useful pharmaceuticals to people worldwide as well as in Japan we make every effort in applying advanced R&D to all of our new pharmaceuticals. Aiming at improving customer satisfaction we also provide all relevant information with regard to our drug products.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,